198 related articles for article (PubMed ID: 29313669)
21. Andrographolide derivatives inhibit guanine nucleotide exchange and abrogate oncogenic Ras function.
Hocker HJ; Cho KJ; Chen CY; Rambahal N; Sagineedu SR; Shaari K; Stanslas J; Hancock JF; Gorfe AA
Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10201-6. PubMed ID: 23737504
[TBL] [Abstract][Full Text] [Related]
22. Selective Targeting of the KRAS G12C Mutant: Kicking KRAS When It's Down.
Hobbs GA; Wittinghofer A; Der CJ
Cancer Cell; 2016 Mar; 29(3):251-253. PubMed ID: 26977877
[TBL] [Abstract][Full Text] [Related]
23. Raman difference studies of GDP and GTP binding to c-Harvey ras.
Wang JH; Xiao DG; Deng H; Webb MR; Callender R
Biochemistry; 1998 Aug; 37(31):11106-16. PubMed ID: 9693007
[TBL] [Abstract][Full Text] [Related]
24. Structural insight into the rearrangement of the switch I region in GTP-bound G12A K-Ras.
Xu S; Long BN; Boris GH; Chen A; Ni S; Kennedy MA
Acta Crystallogr D Struct Biol; 2017 Dec; 73(Pt 12):970-984. PubMed ID: 29199977
[TBL] [Abstract][Full Text] [Related]
25. Revealing the mechanism of action of a first-in-class covalent inhibitor of KRASG12C (ON) and other functional properties of oncogenic KRAS by
Sharma AK; Pei J; Yang Y; Dyba M; Smith B; Rabara D; Larsen EK; Lightstone FC; Esposito D; Stephen AG; Wang B; Beltran PJ; Wallace E; Nissley DV; McCormick F; Maciag AE
J Biol Chem; 2024 Feb; 300(2):105650. PubMed ID: 38237681
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of free radical nitric oxide-mediated Ras guanine nucleotide dissociation.
Heo J; Prutzman KC; Mocanu V; Campbell SL
J Mol Biol; 2005 Mar; 346(5):1423-40. PubMed ID: 15713491
[TBL] [Abstract][Full Text] [Related]
27. Three-dimensional models of the GDP and GTP forms of the guanine nucleotide domain of Escherichia coli elongation factor Tu.
Jurnak F; Heffron S; Schick B; Delaria K
Biochim Biophys Acta; 1990 Aug; 1050(1-3):209-14. PubMed ID: 2119811
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the GDP/GTP exchange reaction of ras p21 by aluminum ion.
Landino LM; Macdonald TL
J Inorg Biochem; 1997 May; 66(2):99-102. PubMed ID: 9112760
[TBL] [Abstract][Full Text] [Related]
29. Drugging an undruggable pocket on KRAS.
Kessler D; Gmachl M; Mantoulidis A; Martin LJ; Zoephel A; Mayer M; Gollner A; Covini D; Fischer S; Gerstberger T; Gmaschitz T; Goodwin C; Greb P; Häring D; Hela W; Hoffmann J; Karolyi-Oezguer J; Knesl P; Kornigg S; Koegl M; Kousek R; Lamarre L; Moser F; Munico-Martinez S; Peinsipp C; Phan J; Rinnenthal J; Sai J; Salamon C; Scherbantin Y; Schipany K; Schnitzer R; Schrenk A; Sharps B; Siszler G; Sun Q; Waterson A; Wolkerstorfer B; Zeeb M; Pearson M; Fesik SW; McConnell DB
Proc Natl Acad Sci U S A; 2019 Aug; 116(32):15823-15829. PubMed ID: 31332011
[TBL] [Abstract][Full Text] [Related]
30. SmgGDS displays differential binding and exchange activity towards different Ras isoforms.
Vikis HG; Stewart S; Guan KL
Oncogene; 2002 Apr; 21(15):2425-32. PubMed ID: 11948427
[TBL] [Abstract][Full Text] [Related]
31. The higher level of complexity of K-Ras4B activation at the membrane.
Jang H; Banerjee A; Chavan TS; Lu S; Zhang J; Gaponenko V; Nussinov R
FASEB J; 2016 Apr; 30(4):1643-55. PubMed ID: 26718888
[TBL] [Abstract][Full Text] [Related]
32. Kinetic mechanisms of mutation-dependent Harvey Ras activation and their relevance for the development of Costello syndrome.
Wey M; Lee J; Jeong SS; Kim J; Heo J
Biochemistry; 2013 Nov; 52(47):8465-79. PubMed ID: 24224811
[TBL] [Abstract][Full Text] [Related]
33. Delineating the RAS Conformational Landscape.
Parker MI; Meyer JE; Golemis EA; Dunbrack RL
Cancer Res; 2022 Jul; 82(13):2485-2498. PubMed ID: 35536216
[TBL] [Abstract][Full Text] [Related]
34. Isoform-Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D.
Johnson CW; Lin YJ; Reid D; Parker J; Pavlopoulos S; Dischinger P; Graveel C; Aguirre AJ; Steensma M; Haigis KM; Mattos C
Cell Rep; 2019 Aug; 28(6):1538-1550.e7. PubMed ID: 31390567
[TBL] [Abstract][Full Text] [Related]
35. Improved binding of raf to Ras.GDP is correlated with biological activity.
Kiel C; Filchtinski D; Spoerner M; Schreiber G; Kalbitzer HR; Herrmann C
J Biol Chem; 2009 Nov; 284(46):31893-902. PubMed ID: 19776012
[TBL] [Abstract][Full Text] [Related]
36. Purification of a factor capable of stimulating the guanine nucleotide exchange reaction of ras proteins and its effect on ras-related small molecular mass G proteins.
Huang YK; Kung HF; Kamata T
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8008-12. PubMed ID: 2172971
[TBL] [Abstract][Full Text] [Related]
37. Affinity labeling of c-H-ras p21 consensus elements with periodate-oxidized GDP and GTP.
Löw A; Sprinzl M; Faulhammer HG
Eur J Biochem; 1993 Jul; 215(2):473-9. PubMed ID: 8393791
[TBL] [Abstract][Full Text] [Related]
38. NMR in integrated biophysical drug discovery for RAS: past, present, and future.
Marshall CB; KleinJan F; Gebregiworgis T; Lee KY; Fang Z; Eves BJ; Liu NF; Gasmi-Seabrook GMC; Enomoto M; Ikura M
J Biomol NMR; 2020 Nov; 74(10-11):531-554. PubMed ID: 32804298
[TBL] [Abstract][Full Text] [Related]
39. The T-cell receptor zeta chain contains a GTP/GDP binding site.
Peter ME; Hall C; Rühlmann A; Sancho J; Terhorst C
EMBO J; 1992 Mar; 11(3):933-41. PubMed ID: 1547789
[TBL] [Abstract][Full Text] [Related]
40. Ab initio study of the role of lysine 16 for the molecular switching mechanism of Ras protein p21.
Futatsugi N; Hata M; Hoshino T; Tsuda M
Biophys J; 1999 Dec; 77(6):3287-92. PubMed ID: 10585950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
